Edition:
India

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

87.78EUR
22 Jun 2018
Change (% chg)

€1.02 (+1.18%)
Prev Close
€86.76
Open
€86.66
Day's High
€87.78
Day's Low
€86.40
Volume
390,332
Avg. Vol
620,337
52-wk High
€93.82
52-wk Low
€76.42

Chart for

About

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the... (more)

Overall

Beta: 0.37
Market Cap(Mil.): €25,665.52
Shares Outstanding(Mil.): 307.96
Dividend: 0.96
Yield (%): 1.15

Financials

FMC takes stake in Humacyte in bet on bioengineered blood vessel

FRANKFURT Germany's Fresenius Medical Care (FMC) has agreed to take a $150 million stake in U.S. tissue engineering firm Humacyte Inc. and will become the exclusive distributor of the company's bioengineered blood vessels once they win approval.

11 Jun 2018

FMC takes stake in Humacyte in bet on bioengineered blood vessel

FRANKFURT, June 11 Germany's Fresenius Medical Care (FMC) has agreed to take a $150 million stake in U.S. tissue engineering firm Humacyte Inc. and will become the exclusive distributor of the company's bioengineered blood vessels once they win approval.

11 Jun 2018

BRIEF-Fresenius Medical Care CEO: Looking To Pick-Up M&A Pace

* CEO TELLS Q1 ANALYST CALL WE ARE LOOKING TO BE MORE ACTIVE IN THE ACQUISITION ARENA; IT'S SMALL THINGS Further company coverage: (Reporting By Berlin Newsroom)

03 May 2018

Deals of the day-Mergers and acquisitions

April 23 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

24 Apr 2018

Jilted Akorn sues Fresenius over deal termination

FRANKFURT U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement.

23 Apr 2018

Fresenius pulls out of Akorn takeover over data integrity

BERLIN German healthcare group Fresenius SE said it had decided to pull out of its planned acquisition of Akorn after it found data integrity breaches at the U.S. generic drug maker.

23 Apr 2018

UPDATE 1-Fresenius Medical cuts 2018 sales target after drug dosage shift

* Now sees 2018 revenue growth of 5-7 pct at constant currency

22 Apr 2018

Fresenius Medical sells U.S. Sound Inpatient for $2.15 billion

BERLIN German dialysis specialist Fresenius Medical Care is selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15 billion, it said on Saturday.

21 Apr 2018

Fresenius Medical sells U.S. Sound Inpatient for $2.15 bln

BERLIN, April 21 German dialysis specialist Fresenius Medical Care is selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15 billion euros, it said on Saturday.

21 Apr 2018

BRIEF-Fresenius Medical Care Q4 Net Income 394 Mln Euros, Up 16 Pct At Constant Currency

* SAYS FOR 2018, CO EXPECTS REVENUE GROWTH OF AROUND 8 PERCENT AT CONSTANT CURRENCY‍​

27 Feb 2018

Earnings vs. Estimates